Point72 Hong Kong LTD Staar Surgical CO Transaction History

Point72 Hong Kong LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$30.6 - $43.78 $702,392 - $1 Million	22,954 New	22,954 $716,000
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $177,292 - $280,400	2,513 New	2,513 $177,000
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $63,720 - $102,756	-1,099 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $96,733 - $140,441	1,099 New	1,099 $100,000
Q3 2021 Nov 15, 2021	SELL	$122.75 - $162.68 $41,980 - $55,636	-342 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$105.76 - $154.96 $11,104 - $16,270	-105 Reduced 23.49%	342 $52,000
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $35,089 - $56,536	447 New	447 $47,000
Q1 2020 May 15, 2020	SELL	$25.01 - $42.4 $2,025 - $3,434	-81 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$24.55 - $38.13 $1,988 - $3,088	81 New	81 $3,000
Q2 2019 Aug 14, 2019	SELL	$23.08 - $37.01 $17,563 - $28,164	-761 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$27.81 - $40.78 $21,163 - $31,033	761 New	761 $26,000
Q3 2018 Nov 14, 2018	SELL	$30.85 - $50.65 $1,326 - $2,177	-43 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.95 - $32.65 $599 - $1,403	43 New	43 $1,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.15B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.